Seeing Is Believing
Currently out of the existing stock ratings of Bill Sutherland, 132 are a BUY (89.19%), 16 are a HOLD (10.81%).
Analyst Bill Sutherland works at BENCHMARK with a stock forecast success ratio of 24.9% fulfilled within 122.52 days on average.
Bill Sutherland’s has documented 291 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on OMCL, Omnicell at 03-May-2024.
Analyst best performing recommendations are on AUGX (AUGMEDIX).
The best stock recommendation documented was for AUGX (AUGMEDIX) at 3/31/2023. The price target of $5 was fulfilled within 88 days with a profit of $3.26 (187.36%) receiving and performance score of 21.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
101
$8.92 (9.69%)
101
9 days ago
1/7 (14.29%)
$9.84 (10.79%)
45
Hold
1 months 8 days ago
5/10 (50%)
$12.13 (9.49%)
99
Hold
101
$8.92 (9.69%)
84
9 months 3 days ago
1/3 (33.33%)
$10.16 (11.18%)
28
Hold
101
$8.92 (9.69%)
100
9 months 7 days ago
0/5 (0%)
$10.5 (11.60%)
Hold
98
$5.92 (6.43%)
200
9 months 28 days ago
11/15 (73.33%)
$6.69 (7.33%)
121
Which stock is Bill Sutherland is most bullish on?
Which stock is Bill Sutherland is most reserved on?
What Year was the first public recommendation made by Bill Sutherland?